Is airway inflammation in chronic obstructive pulmonary disease (COPD) a risk factor for cardiovascular events? (Q36760107)

16 August 2017

0 references

1 reference

title

Is airway inflammation in chronic obstructive pulmonary disease (COPD) a risk factor for cardiovascular events? (English)

1 reference

chronic obstructive pulmonary disease

16 August 2017

0 references

1 reference

Peter M A Calverley

1

1 reference

16 August 2017

Stephen Scott

series ordinal

2

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

COPD: Journal of Chronic Obstructive Pulmonary Disease

16 August 2017

published in

1 reference

16 August 2017

volume

3

1 reference

16 August 2017

issue

4

1 reference

16 August 2017

page(s)

233-242

1 reference

The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Impact of preventing exacerbations on deterioration of health status in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Time course of recovery of health status following an infective exacerbation of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Contribution of respiratory disease to nonrespiratory mortality associations with air pollution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Passive smoking and the risk of coronary heart disease--a meta-analysis of epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Cardiovascular morbidity and mortality in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Predictors of cardiac and noncardiac mortality among 14,697 patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Hospitalizations and mortality in the Lung Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Pathophysiology of airflow limitation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

The nature of small-airway obstruction in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Exacerbations of Bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

C-reactive protein and other inflammatory risk markers in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Inflammatory biomarkers of the patient with myocardial insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

C-reactive protein and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Circulating markers of inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Effects of statins on inflammation in patients with acute and chronic coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Inflammatory pathways in atherosclerosis and acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Interactions between inflammation, oxidative stress, and endothelial dysfunction in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

The association between periodontal diseases and cardiovascular diseases: a state-of-the-science review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Is there a link between periodontal disease and coronary heart disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

A rational approach to pathogenesis and treatment of type 2 diabetes mellitus, insulin resistance, inflammation, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Asymptotic dental score and prevalent coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Plasma cytokine levels predict mortality in patients with acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

The pathophysiology of cigarette smoking and cardiovascular disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Mechanisms of chronic airway obstruction in smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Oxidative stress and smoking-induced vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Smoking and endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Cigarette smoke extract inhibits angiogenesis of pulmonary artery endothelial cells: the role of calpain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Cigarette smoking, endothelial injury and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Oxidative stress and airway inflammation in severe exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Controversies in ventricular remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Respiratory infection and coronary heart disease: progression of a paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Infections and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Azithromycin for the secondary prevention of coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Active and passive smoking, chronic infections, and the risk of carotid atherosclerosis: prospective results from the Bruneck Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Glucose metabolism in chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Insulin signalling and resistance in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

The role of statins in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Effects of rosiglitazone alone and in combination with atorvastatin on the metabolic abnormalities in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

COPD: is there light at the end of the tunnel?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Inhaled corticosteroids and hospitalisation due to exacerbation of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

The TORCH (towards a revolution in COPD health) survival study protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Saskatchewan Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977544

10.1080/15412550600977544

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference